
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BENADRYL | McNeil Pharmaceutical | N-005845 DISCN | 1982-01-01 | 3 products |
| BENADRYL | McNeil Pharmaceutical | N-006146 DISCN | 1982-01-01 | 2 products, RLD |
| BENADRYL PRESERVATIVE FREE | McNeil Pharmaceutical | N-009486 DISCN | 1982-01-01 | 1 products, RLD |
| BENYLIN | Pfizer | N-006514 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
|---|---|---|
| acetadryl | OTC monograph not final | 2013-11-12 |
| acetaflu nighttime | OTC monograph final | 2020-03-26 |
| acetaflu nighttime effervescent | OTC monograph final | 2020-03-26 |
| acetamax pm | OTC monograph not final | 2020-08-31 |
| acetaminophen 500mg diphenhydramine hcl 25mg | OTC monograph not final | 2020-11-16 |
| acetaminophen and diphenhydramine citrate | C200263 | 2025-10-02 |
| acetaminophen and diphenhydramine hcl | C200263 | 2025-12-19 |
| acetaminophen and diphenhydramine hydrochloride | C200263 | 2025-07-02 |
| acetaminophen diphenhydramine hcl | C200263 | 2025-12-22 |
| acetaminophen liquid / acetaminophen diphenhydramine hcl liquid | C200263 | 2025-10-09 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | 1 | — | 2 |
| Common cold | D003139 | EFO_0007214 | J00 | 1 | — | — | 1 | — | 2 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | 1 | — | 1 |
| Bacterial infections | D001424 | — | A49 | — | — | — | 1 | — | 1 |
| Anthrax | D000881 | — | A22 | — | — | — | 1 | — | 1 |
| Vomiting | D014839 | — | R11.1 | — | — | — | 1 | — | 1 |
| Nausea | D009325 | — | R11.0 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | 1 | 2 |
| Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
| Cognitive dysfunction | D060825 | — | G31.84 | 1 | — | — | — | — | 1 |
| Cognition disorders | D003072 | — | — | 1 | — | — | — | — | 1 |
| Neurocognitive disorders | D019965 | — | F09 | 1 | — | — | — | — | 1 |
| Infections | D007239 | EFO_0000544 | — | 1 | — | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | — | 1 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | — | — | — | 1 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
| Back pain | D001416 | — | M54 | — | — | — | — | 1 | 1 |
| Drug common name | Diphenhydramine |
| INN | diphenhydramine |
| Description | Diphenhydramine is an ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. It has a role as a H1-receptor antagonist, an antiemetic, a sedative, an anti-allergic agent, a muscarinic antagonist, an antiparkinson drug, an antipruritic drug, a local anaesthetic, an antidyskinesia agent, an antitussive and a oneirogen. It is an ether and a tertiary amino compound. |
| Classification | Small molecule |
| Drug class | first-generation antihistamine (ethanolamine), anticholinergic, hallucinogen (deliriant) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CN(C)CCOC(c1ccccc1)c1ccccc1 |
| PDB | — |
| CAS-ID | 58-73-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL657 |
| ChEBI ID | 4636 |
| PubChem CID | 3100 |
| DrugBank | DB01075 |
| UNII ID | 8GTS82S83M (ChemIDplus, GSRS) |



















































